Proton therapy is a technically advanced type of radiation therapy treatment that can provide necessary doses of radiation. It takes just minutes to offer a high range of radiation in several treatment sessions. Proton therapy utilizes improved subatomic particles called protons to forward a high level of energy directly to the tumour site with the help of a magnetically guided beam.
During proton therapy, particles of the proton are accelerated to around two-thirds of the light speed, or nearly 100,000 miles per second, to destroy cancer cells. Proton therapy differs from conventional radiation therapy in the use of energy for a patient. Benefits of proton therapy are reduced risk of treatment-induced disorders, improved quality of life during and after treatment, accurate dose delivery, and fewer side effects than IMRT (Intensity Modulated Radiotherapy).
Research & development in proton therapy is expected to offer lucrative growth opportunities for players in the global proton therapy industry. For instance, in April 2020, researchers from Samsung Medical Canter (South Korea) reported examining the targeting of checkpoint kinase 1 as an effective strategy to potentiate therapy in human triple-negative breast cancer cells.
Likewise, growing healthcare expenditure, advanced medicine, and increasing prevalence of cancer have driven the growth of the global market. Another major growth driver for the market is faster uptake and premium pricing. Apart from these, product pricing, reimbursement rate, and adoption rate are expected to influence the future scenario of the global proton therapy market. On the other hand, pricing can become a restraint when it comes to the affordability of devices by various small hospital setups.
The adoption of proton therapy with other therapies will support the growth of the global proton therapy market. For instance, in September 2019, experts from Southern Tohoku Proton Therapy Centre, Japan, found that proton therapy, combined with intra-arterial infusion chemotherapy, helped establish the control on the prime tumor.
It also helped in improving the patient’s health in the curing stage IV of adenoid cystic carcinoma of the tongue. An increase in the number of cancer patients, increasing awareness among people, a rise in the consumption of tobacco, development in insurance coverage for proton therapy, and an increase in demand for proton therapy are some of the key factors that are driving the global proton therapy market.
Tobacco use has been found to be related to increased risk of various cancers such as lung, pharynx, bladder, esophagus, oral cavity, kidney, liver, pancreas, bowel, cervix, leukemia, stomach, larynx, and ovarian. According to the (WHO) World Health Organization, in 2015, about 1.1 billion people consumed tobacco, and the number has been increasing continuously over the years.
Technological developments and growth in healthcare expenditure are the other factors that are expected to boost the growth of the global proton therapy market. On the other hand, the high treatment cost is a restraint of the global proton therapy market.
Global Proton Therapy Market, By Product Type
In terms of product type, the equipment segment held the largest share in 2016. Increasing technological advancements and rising adoption of proton therapy are factors responsible for the growth of this segment. Likewise, the growing prevalence of cancer, increasing hospital investments, and reduced costs of equipment will drive the market.
Global Proton Therapy Market, By Room Type
On considering room type, the multi-room systems segment contributed to the largest share in the market in 2016. Multi-room equipment used as one system to offer treatment to more than two rooms at the same time. This has led to the growth of this segment. Likewise, increasing investment in hospitals and the development of multi-room centres have also contributed to the growth of this segment.
Global Proton Therapy Market, By Geographical Regions
North America holds a major share in the global proton therapy market owing to technological developments, increasing adoption of treatment processes, and a rise in the occurrence of cancer. According to the ACS (American Cancer Society), around 1,688,780 new cancer cases were diagnosed in the United States in 2017.
Europe is the second highest market for proton therapy. The rising use of tobacco has led to the growth of the proton therapy market across the region. According to Eurostat, statistical office of the European Union, one in four European citizens over 15 years old (24%) are tobacco addicted. The market in the Asia Pacific is likely to expand at a higher development rate owing to the growing awareness among people, a large population base, and an increase in healthcare spending.
Key Market Developments
Some Key Findings of the Global Proton Therapy Market Report Include:
By Room Type:
Detailed scope covering all the major segments in the market
In line data validations to ensure data precision
Market recommendations supporting decision making processes
Round the clock analyst support to resolve your queries
Up to 15% additional free customization to meet your specific requirements